Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
18h agoen
From the article
Conditions : Adolescence Obesity Interventions : Drug: Efsubaglutide Alfa 5 mg QW; Drug: Efsubaglutide Alfa 10 mg QW; Drug: Efsubaglutide Alfa 20 mg QW; Drug: Efsubaglutide Alfa placebo Sponsors : Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
https://doi.org/10.1056/NEJMoa2516491
doi.org·29d ago
https://doi.org/10.1056/NEJMoa2517384
doi.org·1mo ago
Preparing for Your First Semaglutide Injection: What You Need to Know
ltcnews.com·2y ago
Novo Nordisk launches first GLP-1 weight loss pill Wegovy in US at lower price than injections
Novo Nordisk has launched the first pill version of its blockbuster GLP-1 weight loss drug Wegovy in the US at a significantly lower price t
theguardian.com·6mo agoGSK initiates phase III programme for novel type 2 diabetes medication, Syncria® (albiglutide)
GSK·17y ago
Semaglutide slows epigenetic aging in a randomized trial of HIV-associated lipohypertrophy
doi.org·17d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.